{
    "id": 7790,
    "fullName": "CDKN2A A68fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "CDKN2A A68fs results in a change in the amino acid sequence of the Cdkn2a protein beginning at aa 68 of 156, likely resulting in premature truncation of the functional protein (UniProt.org). A68fs has not been characterized, however, nonsense mutations downstream of A68 are inactivating (PMID: 9053859, PMID: 8668202), thus A68fs is predicted to lead to a loss of Cdkn2a protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3063,
                    "pubMedId": 9053859,
                    "title": "Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9053859"
                },
                {
                    "id": 3108,
                    "pubMedId": 8668202,
                    "title": "Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/8668202"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1029,
        "geneSymbol": "CDKN2A",
        "terms": [
            "CDKN2A",
            "ARF",
            "CDK4I",
            "CDKN2",
            "CMM2",
            "INK4",
            "INK4A",
            "MLM",
            "MTS-1",
            "MTS1",
            "P14",
            "P14ARF",
            "P16",
            "P16-INK4A",
            "P16INK4",
            "P16INK4A",
            "P19",
            "P19ARF",
            "TP16"
        ]
    },
    "variant": "A68fs",
    "createDate": "06/17/2015",
    "updateDate": "06/21/2015",
    "referenceTranscriptCoordinates": {
        "id": 105280,
        "transcript": "NM_000077",
        "gDna": "chr9:g.(21971157_21971158)",
        "cDna": "c.(202_201)",
        "protein": "p.A68fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15200,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Verzenio (abemaciclib) treatment inhibited Rb1 phosphorylation and tumor growth in patient-derived xenograft (PDX) models of head and neck squamous cell carcinoma harboring CCND1 amplification and CDKN2A A68fs (PMID: 30380421).",
            "molecularProfile": {
                "id": 30826,
                "profileName": "CCND1 amp CDKN2A A68fs"
            },
            "therapy": {
                "id": 802,
                "therapyName": "Abemaciclib",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12822,
                    "pubMedId": 30380421,
                    "title": "Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30380421"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 7683,
            "profileName": "CDKN2A A68fs",
            "profileTreatmentApproaches": [
                {
                    "id": 16204,
                    "name": "CDK4 Inhibitor",
                    "profileName": "CDKN2A A68fs"
                },
                {
                    "id": 16202,
                    "name": "CDK6 Inhibitor",
                    "profileName": "CDKN2A A68fs"
                },
                {
                    "id": 16205,
                    "name": "CDK4/6 Inhibitor",
                    "profileName": "CDKN2A A68fs"
                },
                {
                    "id": 16203,
                    "name": "CDK Inhibitor (Pan)",
                    "profileName": "CDKN2A A68fs"
                }
            ]
        },
        {
            "id": 30826,
            "profileName": "CCND1 amp CDKN2A A68fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 105283,
            "transcript": "XM_011517675",
            "gDna": "chr9:g.(21971157_21971158)",
            "cDna": "c.(202_201)",
            "protein": "p.A68fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 105281,
            "transcript": "NM_001195132",
            "gDna": "chr9:g.(21971157_21971158)",
            "cDna": "c.(202_201)",
            "protein": "p.A68fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 105282,
            "transcript": "XM_011517676",
            "gDna": "chr9:g.(21971157_21971158)",
            "cDna": "c.(202_201)",
            "protein": "p.A68fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 105280,
            "transcript": "NM_000077",
            "gDna": "chr9:g.(21971157_21971158)",
            "cDna": "c.(202_201)",
            "protein": "p.A68fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}